Zuellig Pharma
Zuellig Pharma is one of the largest healthcare services groups in Asia and our purpose is to make healthcare more accessible. We provide world-class distribution, digital and commercial services to support the growing healthcare needs in this region.
See below for the Latest Zuellig Pharma News, Analysis, Profit Results, Share Price Information, and Commentary.
ZP Therapeutics earns dual accolades at the Healthcare Asia Pharma Awards
ZP Therapeutics earns dual accolades at the Healthcare Asia Pharma Awards
The commercialisation division of Zuellig Pharma claims the Most Differentiated Service of the Year and Outcomes-based Contracting Model of the Year titles.
Most Read
1. Sunway Healthcare targets $4.34b market cap with Malaysia IPO 2. 2026 biotech playbook: Hong Kong at the centre of China’s globalisation 3. Aging population drives demand for durable medical equipment market 4. Hong Kong outlines ‘One plus Three’ model for life and health tech R&D 5. IHH Healthcare FY2025 net profit falls 21% to $682.67mResource Center
Read Here
Advertise
Sign Up
Events
Event News
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
Commentary
2026 biotech playbook: Hong Kong at the centre of China’s globalisation